Evidence map›Paper›PMID 35082762›Full record

ArticleFrontiers in endocrinology2021

Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis.

Li-Min Zhao, Xie-Hui Chen, Mei Qiu

Open access · goldAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role?Journal of cardiovascular development and disease · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Li-Min ZhaoDepartment of Geriatric Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Xie-Hui ChenDepartment of Geriatric Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Mei QiuDepartment of General Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Longgang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsHumansHypoglycemic AgentsSARS-CoV-2Hypoglycemic AgentsSodium-Glucose Transporter 2 InhibitorsCOVID- 19deathDPP4 (dipeptidyl peptidase 4) inhibitorsglp1 agonistsSGLT2Itype 2 diabetes mellitus

Identifiers

PMID35082762
PMCPMC8785330
OpenAlexW4206262981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.